FGF9 anticorps (C-Term)
Aperçu rapide pour FGF9 anticorps (C-Term) (ABIN7184903)
Antigène
Voir toutes FGF9 (FGF-9) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of Human FGF-9.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:2000, ELISA:1:20000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- FGF9 (FGF-9) (Fibroblast Growth Factor 9 (FGF-9))
-
Autre désignation
- FGF9
-
Sujet
- FGF 9 antibody, FGF-9 antibody, FGF9 antibody, FGF9_HUMAN antibody, Fibroblast growth factor 9 antibody, GAF (Glia-activafibroblast growth factor 9 (glia-activating factor) antibody, GAF antibody, Glia Activating Factor antibody, Glia-activating factor antibody, HBFG 9 antibody, HBFG9 antibody, HBGF-9 antibody, Heparin-binding growth factor 9 antibody, MGC119914 antibody, MGC119915 antibody, SYNS3 antibody
-
UniProt
- P31371
Antigène
-